Evidence map›Paper›PMID 24684608›Full record

ArticleGenes, brain, and behavior2014

Extinction of an instrumental response: a cognitive behavioral assay in Fmr1 knockout mice.

M S Sidorov, D D Krueger, M Taylor, E Gisin, E K Osterweil, M F Bear

Open access · bronzeAbstract read
In one paragraph

Article in Genes, brain, and behavior, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. How TRPC Channels Modulate Hippocampal Function.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Review
  8. Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  9. Article
  10. Review
  11. Modeling fragile X syndrome in the Fmr1 knockout mouse.Intractable & rare diseases research · 2014
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

M S SidorovThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
D D KruegerThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
M TaylorThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
E GisinThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
E K OsterweilThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
M F BearThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Massachusetts Institute of Technology · USMax Planck Institute of Experimental Medicine · DE

Funding

Mechanisms and Functions of FMRP in Neuronal DevelopmentR01HD046943 · NICHD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2003 to 2014
$2.9M
Training Program in the Neurobiology of Learning and MemoryT32MH074249 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEAR, MARK F · 2007 to 2016
$1.7M
Expiratory muscle training in patients with Parkinson'sR21HD046903 · NICHD · UNIVERSITY OF FLORIDA · PI SAPIENZA, CHRISTINE M · 2005 to 2006
$397k
NICHD NIH HHS 5R01HD046903NICHD NIH HHS R01 HD046943NICHD NIH HHS R21 HD046903NIMH NIH HHS 2T32MH074249NIMH NIH HHS T32 MH074249
6 · The paper itself

Abstract

Fragile X (FX) is the most common genetic cause of intellectual disability and autism. Previous studies have shown that partial inhibition of metabotropic glutamate receptor signaling is sufficient to correct behavioral phenotypes in a mouse model of FX, including audiogenic seizures, open-field hyperactivity and social behavior. These phenotypes model well the epilepsy (15%), hyperactivity (20%) and autism (30%) that are comorbid with FX in human patients. Identifying reliable and robust mouse phenotypes to model cognitive impairments is critical considering the 90% comorbidity of FX and intellectual disability. Recent work characterized a five-choice visuospatial discrimination assay testing cognitive flexibility, in which FX model mice show impairments associated with decreases in synaptic proteins in prefrontal cortex (PFC). In this study, we sought to determine whether instrumental extinction, another process requiring PFC, is altered in FX model mice, and whether downregulation of metabotropic glutamate receptor signaling pathways is sufficient to correct both visuospatial discrimination and extinction phenotypes. We report that instrumental extinction is consistently exaggerated in FX model mice. However, neither the extinction phenotype nor the visuospatial discrimination phenotype is corrected by approaches targeting metabotropic glutamate receptor signaling. This work describes a novel behavioral extinction assay to model impaired cognition in mouse models of neurodevelopmental disorders, provides evidence that extinction is exaggerated in the FX mouse model and suggests possible limitations of metabotropic glutamate receptor-based pharmacotherapy.

Indexed as

Conditioning, OperantExtinction, PsychologicalAnimalsCognitionFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeMaleMiceMice, Inbred C57BLPhenotypePrefrontal CortexVisual PerceptionFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Fragile Xinstrumental extinctionintellectual disabilitylovastatinmetabotropic glutamate receptor 5

Identifiers

PMID24684608
PMCPMC4182346
OpenAlexW2014790792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.